Related Experiment Video
Updated: Aug 4, 2026

12:09
Transient Expression and Cellular Localization of Recombinant Proteins in Cultured Insect Cells
Published on: April 20, 2017
Production of functional antibodies generated in a nonlytic insect cell expression system
1Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Protein Expression and Purification
|February 13, 2001
Summary
Researchers developed a novel method for producing adenovirus type 2 (Ad2) penton base antibodies in insect cells. This nonlytic expression system efficiently generates functional recombinant antibodies, offering advantages over traditional methods.
Area of Science:
- Biotechnology
- Molecular Biology
- Immunology
Background:
- Adenovirus type 2 (Ad2) penton base protein is a key target for antiviral therapies.
- Existing recombinant antibody production methods can be limited by proteolytic degradation and slow expression analysis.
Purpose of the Study:
- To develop and characterize a nonlytic insect cell expression system for producing monoclonal antibodies against Ad2 penton base protein.
- To explore the generation of bifunctional antibodies by fusing therapeutic genes to antibody domains.
Main Methods:
- Cloning and expression of immunoglobulin genes in Spodoptera frugiperda (Sf9) cells using a nonlytic vector system.
- Utilizing the Orgyia pseudotsugata multicapsid nucleopolyhedrosis virus immediate-early 2 (OpIE2) promoter for gene expression.
- Generating bifunctional antibodies by gene fusion with growth factors or cytokines.
Main Results:
- Transfected Sf9 cells continuously secreted functional monoclonal antibodies recognizing Ad2 penton base protein.
- The nonlytic system allowed for rapid assessment of antibody quantity and activity.
- Recombinant antibodies showed reduced proteolytic degradation compared to cytolytic baculovirus systems.
- Antibody production levels were comparable to those from cytolytic baculovirus vectors.
Conclusions:
- A nonlytic insect cell system provides an efficient and stable platform for producing recombinant Ad2 penton base antibodies.
- This system facilitates the development of bifunctional antibodies with potential therapeutic applications.
- The nonlytic approach offers advantages in terms of protein stability and faster analysis compared to lytic systems.

